NABILONE SIGNIFICANTLY IMPROVES AGITATION/AGGRESSION IN PATIENTS WITH MODERATE-TO-SEVERE AD: PRELIMINARY RESULTS OF A PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER TRIAL